Premium
New Generation Hole Transporting Materials for Perovskite Solar Cells: Amide‐Based Small‐Molecules with Nonconjugated Backbones
Author(s) -
Petrus Michiel L.,
Schutt Kelly,
Sirtl Maximilian T.,
Hutter Eline M.,
Closs Anna C.,
Ball James M.,
Bijleveld Johan C.,
Petrozza Annamaria,
Bein Thomas,
Dingemans Theo J.,
Savenije Tom J.,
Snaith Henry,
Docampo Pablo
Publication year - 2018
Publication title -
advanced energy materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.08
H-Index - 220
eISSN - 1614-6840
pISSN - 1614-6832
DOI - 10.1002/aenm.201801605
Subject(s) - amide , perovskite (structure) , materials science , conjugated system , energy conversion efficiency , molecule , chemical engineering , combinatorial chemistry , nanotechnology , polymer , optoelectronics , organic chemistry , composite material , chemistry , engineering
State‐of‐the‐art perovskite‐based solar cells employ expensive, organic hole transporting materials (HTMs) such as Spiro‐OMeTAD that, in turn, limits the commercialization of this promising technology. Herein an HTM (EDOT‐Amide‐TPA) is reported in which a functional amide‐based backbone is introduced, which allows this material to be synthesized in a simple condensation reaction with an estimated cost of <$5 g −1 . When employed in perovskite solar cells, EDOT‐Amide‐TPA demonstrates stabilized power conversion efficiencies up to 20.0% and reproducibly outperforms Spiro‐OMeTAD in direct comparisons. Time resolved microwave conductivity measurements indicate that the observed improvement originates from a faster hole injection rate from the perovskite to EDOT‐Amide‐TPA. Additionally, the devices exhibit an improved lifetime, which is assigned to the coordination of the amide bond to the Li‐additive, offering a novel strategy to hamper the migration of additives. It is shown that, despite the lack of a conjugated backbone, the amide‐based HTM can outperform state‐of‐the‐art HTMs at a fraction of the cost, thereby providing a novel set of design strategies to develop new, low‐cost HTMs.